glp-1/gip receptor agonists Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an Free Comparison Chart: GLP-1 and

Tirzepatide Research: Published trials of FDA-approved tirzepatide have shown it acts as a dual GLP-1/GIP receptor agonist, targeting both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) pathways

[PubMed] [Google Scholar] 7.Obesity: identification, assessment and management Clinical guideline

Metabolisms 52(7):908915

The common causes of weight regain include irregular follow up, not following dietary advice and decreased physical activity

Grazul-Bilska AT, Borowicz PP, Johnson ML, Minten MA, Bilski JJ, Wroblewski R, Redmer DA, Reynolds LP

Kuitunen (2024) systematically reviewed two register-based cohorts encompassing 938 pregnancies and similarly found no association between GLP-1 RA exposure and CA, though sample sizes were small and confidence intervals wide